The impact of adjuvant radiotherapy on overall survival in spinal low-grade gliomas: a propensity score-matched analysis
Journal of Neuro-Oncology · 2025
DOI: 10.1007/s11060-024-04880-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2025. Verfasst von Victor Gabriel El-Hajj und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. victor.gabriel.elhajj@stud.ki.se. Hauptthemen laut MEDLINE: Glioma, Spinal Cord Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karolinska Institute.
Abstract (Originalsprache)
Introduction
Spinal low-grade gliomas (sLGGs) are a group of tumors that arise from glial cells in the spinal cord. Current evidence supporting the use of adjuvant radiotherapy for the management of sLGG is lacking. We hence aimed to compare overall survival rates in patients receiving surgery alone with those receiving surgery with adjuvant radiotherapy.
Methods
The NCDB, a large, nationwide, US-based cancer registry was used. Relevant cases were identified using the following ICD-O-3 histological codes: 9382, 9384, 9400, 9410, 9411, 9420, 9421, 9424, 9425, and 9450, along with the ICD-O-3 topographical codes for spinal meninges (C70.1) and spinal cord (C72.0), excluding spinal ependymomas. Overall survival was the primary outcome. Propensity score matching 1:1 was used to balance the cohorts prior to Kaplan-Meier survival analysis.
Results
A total of 552 patients were included in the study, with 440 in the surgery alone group and 156 in the surgery with adjuvant radiotherapy group. Patients in the surgery with adjuvant radiotherapy group were significantly older (median age 40.0 vs. 24.0 years, p < 0.001), and exhibited higher proportions of WHO grade 2 tumors ( p < 0.001). Adjuvant chemotherapy was more frequently administered in the surgery with adjuvant radiotherapy group (23% vs. 7%, p < 0.001). Overall, adjuvant radiotherapy was not associated with improved survival, with a significantly higher mortality in the radiotherapy group before propensity score matching ( p < 0.0001). After matching, the difference in overall survival was no longer significant ( p = 0.11).
Conclusion
This study found no significant overall survival benefit associated with the use of adjuvant radiotherapy for spinal low-grade gliomas (sLGG). Although patients who received adjuvant radiotherapy initially demonstrated higher mortality rates, this difference was largely due to confounding factors such as more advanced disease in this group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. victor.gabriel.elhajj@stud.ki.se.
- Department of Medicine, University of Cambridge, Cambridge, UK.
- Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
- Mayo Clinic Neuro-Informatics Laboratory, Mayo Clinic, Rochester, MN, USA.
- Department of Neurological Surgery, Mayo Clinic, Rochester, MN, USA.
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Förderung
- Karolinska Institute
Zitieren
APA
El-Hajj, V. G., Ranganathan, S., Hoang, H., Ghaith, A. K., Bydon, M., & Elmi-Terander, A. (2025). The impact of adjuvant radiotherapy on overall survival in spinal low-grade gliomas: a propensity score-matched analysis. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04880-3
Vancouver
El-Hajj VG, Ranganathan S, Hoang H, Ghaith AK, Bydon M, Elmi-Terander A. The impact of adjuvant radiotherapy on overall survival in spinal low-grade gliomas: a propensity score-matched analysis. Journal of Neuro-Oncology. 2025. doi:10.1007/s11060-024-04880-3
BibTeX
@article{ElHajj2025,
author = {El-Hajj, Victor Gabriel and Ranganathan, Sruthi and Hoang, Harry and Ghaith, Abdul Karim and Bydon, Mohamad and Elmi-Terander, Adrian},
title = {The impact of adjuvant radiotherapy on overall survival in spinal low-grade gliomas: a propensity score-matched analysis},
journal = {Journal of Neuro-Oncology},
year = {2025},
doi = {10.1007/s11060-024-04880-3}
}
EUVIMED